Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.62%
#2 Venom Venom +23.96%
#3 aelf aelf +10.81%
#4 Decred Decred +10.29%
#5 Status Status +8.08%
#6 DexNet DexNet +7.57%
#7 TRIA TRIA +6.92%
#8 Pons Pons +6.67%
#9 MarsCoin MarsCoin +6.23%
#10 SkyAI SkyAI +6.18%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pharma Equity Group A/S Pharma Equity Group A/S

Pharma Equity Group A/S

PEG
Clasificación en acciones #30414
Operating from Hørsholm, Denmark, Pharma Equity Group A/S is an investment firm... Operating from Hørsholm, Denmark, Pharma Equity Group A/S is an investment firm primarily focused on the life sciences industry. The company strategically provides early-stage capital to ventures that are developing advanced technologies and treatments designed to improve human health and elevate the quality of life.
Precio por acción
$0.01378149
Última sincronización: 2026-08-18
Capitalización bursátil
$16.92M
Cambio (1 día)
-3.13%
Cambio (1 año)
-34.10%
País
DK
Comercio Pharma Equity Group A/S (PEG)

Categoría

Healthcare
Ganancias de Pharma Equity Group A/S (PEG)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Pharma Equity Group A/S, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Pharma Equity Group A/S desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE